About
Tsart Trio 6.25 Tablet is a triple combination medication typically comprising an Angiotensin Receptor Blocker (ARB), a Calcium Channel Blocker (CCB), and a Diuretic (e.g., Telmisartan, Amlodipine, and Hydrochlorothiazide or Chlorthalidone). This powerful combination targets multiple pathways involved in blood pressure regulation. The ARB component relaxes blood vessels, the CCB dilates arteries, and the diuretic increases the excretion of sodium and water, reducing blood volume. This multi-pronged approach provides comprehensive and robust blood pressure control, especially for patients with severe or resistant hypertension.
This medication is indicated for the treatment of essential hypertension when dual therapy is insufficient to achieve target blood pressure levels. By combining three distinct antihypertensive agents, Tsart Trio 6.25 offers superior efficacy in lowering blood pressure and significantly reduces the risk of major cardiovascular events such as stroke, heart attack, and kidney disease. Regular monitoring of blood pressure, electrolytes, and renal function is crucial to ensure optimal therapeutic benefits and patient safety.
Uses
- Treatment of severe essential hypertension
- Management of resistant hypertension
- When dual therapy is inadequate for blood pressure control
- Comprehensive reduction of cardiovascular risk
Directions For Use
Take this tablet orally once daily, with or without food, as directed by your healthcare provider.
Benefits
- Provides maximal blood pressure reduction
- Combines three complementary mechanisms of action
- Highly effective for difficult-to-control hypertension
- Significantly reduces the risk of major cardiovascular events
- Convenient once-daily dosing regimen
- Improves patient adherence to complex treatment plans
Side Effects
- Dizziness
- Headache
- Fatigue
- Peripheral edema (swelling of ankles/feet)
- Hypotension (low blood pressure)
- Electrolyte imbalances (e.g., hypokalemia, hyperkalemia)
- Nausea
- Diarrhea
- Muscle cramps
- Gout exacerbation
- Renal dysfunction
- Cough (less common than with ACE inhibitors)
- Photosensitivity
Safety Measures
- Alcohol - Alcohol can significantly potentiate the hypotensive effects of this triple combination, leading to severe dizziness, lightheadedness, or fainting. Avoid alcohol.
- Pregnancy - Tsart Trio 6.25 Tablet is contraindicated during pregnancy, especially in the second and third trimesters, due to the risk of severe fetal injury or death from the ARB component.
- Breastfeeding - Not recommended during breastfeeding as multiple components are excreted in breast milk and may pose risks to the nursing infant.
- Liver - Use with extreme caution in patients with hepatic impairment. The diuretic component can precipitate hepatic coma in severe liver disease. Dose adjustments are likely needed.
- Kidney - Contraindicated in anuria. Use with extreme caution in severe renal impairment; close monitoring of kidney function and electrolytes is essential, and dose adjustments are required.
- Lung - While generally safe, the diuretic component can rarely cause acute respiratory distress syndrome (ARDS). Monitor for any new or worsening respiratory symptoms.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!